NCT07076901Completed
Prehabilitation Strategies for Patients Undergoing Laparoscopic Sleeve Gastrectomy
Effectiveness of Prehabilitation Strategies in Enhancing Recovery and Postoperative Outcomes in Laparoscopic Sleeve Gastrectomy Patients
Source: ClinicalTrials.gov · Last updated 22 Jul 2025
Brief summary (registry, in English)
This study aims to evaluate the effectiveness of prehabilitation strategies in patients undergoing laparoscopic sleeve gastrectomy (LSG). The study compares a group receiving prehabilitation (including exercise, nutritional, and psychological support) with a control group receiving routine care. The primary goal is to determine if prehabilitation improves postoperative recovery, enhances weight loss, improves quality of life, and reduces complications.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 120 (actual)
- First submitted
- 2 Jul 2025
- Start date
- 1 Jan 2024
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- The First Hospital of Hebei Medical University
- Diseases
- Obesity
- NCT number
- NCT07076901
What you commit to
- Study type: Interventional
- Participants enrolled: 120
- From 1 Jan 2024 to the primary completion date, 31 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Planned pregnancy within 1 year post-surgery.
Other illness
- Presence of mental disorders, cognitive impairment, or consciousness disturbance.
Other
- Incomplete clinical data.
- Inability to strictly adhere to dietary instructions.
- Inability to complete follow-up visits.
- Secondary obesity.
Who the study is looking for
- Obesity, defined by a body mass index (BMI) ≥35 kg/m².
- Age between 18 and 50 years.
- Failure of non-surgical weight loss methods.
- Surgical eligibility for LSG based on clinical assessment.
- Willingness to participate in the study and sign an informed consent form.
Age in the registry: 18 years to 50 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The First Hospital of Hebei Medical University Coordinator of this site? Confirm its status | Shijiazhuang | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.